statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	469
CN - Cina	125
SG - Singapore	109
IT - Italia	99
GB - Regno Unito	84
BR - Brasile	54
DE - Germania	46
SE - Svezia	39
HK - Hong Kong	38
FR - Francia	26
RU - Federazione Russa	25
FI - Finlandia	20
IN - India	20
NL - Olanda	19
ID - Indonesia	15
IE - Irlanda	14
CA - Canada	11
TR - Turchia	11
VN - Vietnam	7
CH - Svizzera	5
CI - Costa d'Avorio	5
CZ - Repubblica Ceca	4
JP - Giappone	4
MY - Malesia	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
BD - Bangladesh	3
CO - Colombia	3
ES - Italia	3
PL - Polonia	3
AU - Australia	2
CL - Cile	2
HU - Ungheria	2
IL - Israele	2
KR - Corea	2
MO - Macao, regione amministrativa speciale della Cina	2
MX - Messico	2
PE - Perù	2
ZA - Sudafrica	2
AL - Albania	1
AR - Argentina	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BO - Bolivia	1
EC - Ecuador	1
ET - Etiopia	1
GR - Grecia	1
GT - Guatemala	1
IQ - Iraq	1
IR - Iran	1
JM - Giamaica	1
KE - Kenya	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PT - Portogallo	1
PY - Paraguay	1
SC - Seychelles	1
UA - Ucraina	1
Totale	1.313

Nome	#
Dyslipidaemia after switch to tenofovir alafenamide (TAF)-based cART regimens in a cohort of HIV-positive patients: what clinical relevance?	192
The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease	177
Declining mortality rate of hospitalised patients in the second wave of the COVID-19 epidemics in Italy : Risk factors and the age-specific patterns	174
Female gender is associated with long COVID syndrome : a prospective cohort study	150
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects	149
Do combination antiretroviral therapy regimens for HIV infection feature diverse T-Cell phenotypes and inflammatory profiles?	143
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19	139
Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy	121
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy	101
Totale	1.346

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	87	0	0	0	0	0	0	17	16	20	13	19	2
2021/2022	173	7	17	8	11	13	16	20	7	29	12	8	25
2022/2023	230	15	18	18	34	20	40	5	23	27	2	19	9
2023/2024	141	9	13	9	18	43	2	11	7	1	8	9	11
2024/2025	367	9	14	0	32	37	20	30	26	18	68	62	51
2025/2026	345	72	81	63	53	47	29	0	0	0	0	0	0
Totale													1.346

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca